Trevena (Trevena) Change In Inventory : $0.01 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Trevena Change In Inventory?

Trevena's change in inventory for the quarter that ended in Dec. 2023 was $0.00 Mil. It means Trevena's inventory declined by $0.00 Mil from Sep. 2023 to Dec. 2023 .

Trevena's change in inventory for the fiscal year that ended in Dec. 2023 was $0.01 Mil. It means Trevena's inventory declined by $0.01 Mil from Dec. 2022 to Dec. 2023 .

Trevena's Total Inventories for the quarter that ended in Dec. 2023 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Trevena's Days Inventory for the quarter that ended in Dec. 2023 was 32.06.

Inventory Turnover measures how fast the company turns over its inventory within a year. Trevena's Inventory Turnover for the quarter that ended in Dec. 2023 was 2.85.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Trevena Change In Inventory Historical Data

The historical data trend for Trevena's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trevena Change In Inventory Chart

Trevena Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-2.35

-0.62

0.01

Trevena Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-0.12	-	0.01	-	-

Trevena Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

Trevena (NAS:TRVN) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Trevena's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.45	/	1.281	*	365 / 4
	=	32.06

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Trevena's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.281	/	0.45
	=	2.85

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Trevena's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.45	/	-0.082
	=	N/A

Trevena Change In Inventory Related Terms

Thank you for viewing the detailed overview of Trevena's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Trevena (Trevena) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trevena Inc (NAS:TRVN) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

6T40:Germany

Address

955 Chesterbrook Boulevard, Suite 110, Chesterbrook, PA, USA, 19087

Website

https://www.trevena.com

Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.

Executives

Mark Corrigan	director
Mark Demitrack	officer: SVP, Chief Medical Officer	955 CHESTERBROOK BOULEVARD, SUITE 200, CHESTERBROOK PA 19087
Robert T Yoder	officer: SVP, Chief Business Officer	955 CHESTERBROOK BOULEVARD, SUITE 110, SUITE 200, CHESTERBROOK PA 19087
Carrie L. Bourdow	director, officer: President & CEO	C/O TREVENA, INC., 1018 WEST 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406
Patricia M. Drake	officer: SVP, Chief Commercial Officer	245 FIRST STREET, SUITE 1800, CAMBRIDGE MA 02142
Barry Shin	officer: SVP, CFO	C/O TREVENA, INC., 955 CHESTERBROOK BLVD, SUITE 110, CHESTERBROOK PA 19087
Marvin Johnson	director	C/O TREVENA, INC., 955 CHESTERBROOK BOULEVARD, STE. 110, CHESTERBROOK PA 19087
Barbara Yanni	director	1018 W. 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406
Moulder Leon O Jr	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jason Raleigh Nunn	director	1119 ST. PAUL STREET, BALTIMORE MD 21202
Scott Braunstein	director	C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR MI 48108
Michael R Dougherty	director	C/O ADOLOR CORP, 700 PENNSYLVANIA DR, EXTON PA 19341
Anne M. Phillips	director	C/O TREVENA, INC., 1018 WEST 8TH AVENUE, KING OF PRUSSIA PA 19406
Scott Applebaum	officer: CLCO; SVP, Regulatory Affairs	C/O TREVENA INC., 955 CHESTERBROOK BOULEVARD, SUITE 110, CHESTERBROOK PA 19087
John P. Hamill	officer: Int. Prin. Fin. Off. and PAO	4092 NEW HOPE ROAD, FURLONG PA 18925